A European Network for the Investigation of Gender Incongruence

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Ghent

About this trial

The physical and psychological effects of the hormonal treatment of transsexual persons are not sufficiently described. 'Transparency' wants to answer this question in a prospective manner, in a multicenter study to describe these effects. The low prevalence of transsexualism was the stimulus to search for European partners for this Protocol. A common standardized hormonal protocol was designed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Transsexual persons older then 18 years, who are not yet treated with hormonal therapy.

Disqualifiers

None

Trial population

transsexual persons older than 18 years, who are not yet treated with hormonal therapy

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • questionnaires

    Other intervention

    a descriptive questionnaire, SF-36, , bone questionnaires, Baecke physical activity questionnaire, voice evaluation

  • blood sampling

    Biological/Vaccine

    LFT (AST, ALT), CRP, creatinine, glucose, Total Cholesterol, Triglycerides, HDL-CH, LDL-CH, 25OH vitamin D, PSA if\> 45 years, Hematocrit, testosterone, sex hormone-binding globulin, free testosterone , oestradiol, prolactin, luteinizing hormone, TSH, androgeengevoeligheids test (CAG RL), oral glucose tolerance test

  • clinical evaluation

    Other intervention

    height, weight, blood pressure, chestcircumference, waist circumference, grip strength, measuring 2 ° and 4 ° finger, and Ferriman Gallwey score

  • Dermatology evaluation

    Other intervention

    Evaluation of the hair pattern, using the Leeds acne classification scale, acne scars through ECCA scale (échelle d'évaluation clinique des cicatrices d'acné), androgenetic alopecia, and sebummetrie

  • Bone evaluation

    Other intervention

    PQCT scanner, BMD assessment

Treatment groups

125 Participants
are divided into 1 treatment group
Group A: transgender people starting hormone treatment5 interventions

Trial outcomes

Primary outcomes

1

physical and psychological effects of the hormonal treatment of transsexual persons

evaluations will be done every 3 months the first year of therapy, every 6 months in the second year, and after sex reassignment surgery annually.

Time frame
annually

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.